查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024473

獸醫分子診斷市場報告：按產品類型、技術、動物種類、疾病、最終用戶和地區分類（2026-2034 年）

Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球獸醫分子診斷市場規模達8.018億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到15.323億美元，2026年至2034年的複合年成長率（CAGR）為7.24%。市場成長的主要促進因素包括：寵物飼養在公眾中日益普及、分子診斷技術的進步，以及獸醫實踐中分子診斷檢測標準化方面日益嚴格的監管指南和品管標準的採用。

獸醫分子診斷市場的發展趨勢：

大眾寵物擁有量增加

寵物飼養量的增加對獸醫分子診斷市場產生了正面影響。寵物飼養量的激增帶動了對獸醫服務（包括診斷服務）的需求成長。例如，根據寵物食品製造商協會2021年3月發布的寵物數據，英國超過59%的家庭擁有寵物，2021年寵物數量超過3,260萬隻。將寵物視為家庭成員的趨勢日益成長，進一步推動了獸醫分子診斷市場的需求。此外，犬貓是寵物飼主最愛的寵物。例如，2022年全球整體約有6.045億隻犬和約4.082億隻貓。此外，美國寵物用品協會（APPA）於2022年4月宣布，2021年美國寵物產業總支出達1,236億美元，高於2020年的1,036億美元。動物醫療保健支出的成長預計將推動獸醫分子診斷市場的發展。這是因為預計大量寵物飼主將使用先進的診斷方法來診斷各種動物疾病，而這被認為是近期獸醫分子診斷市場價格上漲的原因。

動物疾病發生率上升

動物疾病的日益普及正在推動獸醫分子診斷市場的成長。卡加利大學於2021年6月發表的一項研究調查了犬類多房棘球蚴病感染情況，並推斷其在通用感染疾病傳播中的潛在作用。研究表明，多房棘球蚴是一種原產於北半球（亞伯達艾伯塔省）的寄生線蟲，其生命週期通常在終宿主和中間宿主之間循環。然而，在都市區，寵物犬也可能感染這種寄生蟲，由於接近性，這可能對人類構成重大風險。此外，據估計，每年有五分之一的牲畜死於該疾病，還有更多動物受到影響。根據新興病原體研究所於2021年11月發表的報導，育肥場中75%的疾病是由牛的呼吸道疾病引起的，每年對畜牧養殖戶造成超過10億美元的經濟損失。估計費用高達1.5億美元，而酪農因蹄腐病每頭乳牛損失120至350美元。這些不斷增加的損失以及動物遺傳疾病的增加預計將推動對獸醫分子診斷的需求，從而擴大獸醫分子診斷的市場佔有率。

分子診斷技術的進步

分子診斷技術的進步正在推動市場成長。聚合酵素鏈鎖反應(PCR)、次世代定序(NGS) 和微陣列分析等尖端分子診斷技術不斷發展，為獸醫提供無與倫比的動物健康洞察。此外，主要市場參與者正在推出改進的診斷試劑盒和儀器，以促進高品質的診斷和治療。例如，2022 年 4 月，位於綠波市的 Carolina Liquid Chemistries Corp. 簽署了一項半獨家協議，向美國獸醫市場銷售攜帶式分析儀。該公司銷售 Seamaty SMT-120 VP 獸用全自動生化分析儀，這是一款緊湊型全自動生化、電解質、免疫檢測和凝血分析儀，用於動物健康檢查。同樣，2021 年 9 月，Micro Vet Diagnostics 推出了 Micro-chem II，這是一款全新的分析儀，涵蓋生化、電解質、免疫檢測和血液凝固檢驗，用於動物健康檢查。該儀器可提供具有準確基準值和檢查室級品質的結果。這些創新提高了獸醫檢查室的效率，實現了檢測結果的快速交付，預計將在未來幾年推動獸醫分子診斷市場的收入成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球獸醫分子診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 試劑盒和試劑
  • 裝置
  • 軟體和服務

第7章 市場區隔：依技術分類

  • 即時PCR
  • 微陣列
  • DNA定序

第8章 市場區隔：依動物類型分類

  • 伴侶動物
  • 家畜

第9章 市場區隔：依疾病類型分類

  • 媒介傳播疾病
  • 呼吸道病原體
  • 引起腹瀉的細菌
  • 其他

第10章 市場區隔：依最終用戶分類

  • 動物醫院
  • 臨床檢查室
  • 研究機構

第11章 市場區隔：按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第12章 SWOT 分析

第13章：價值鏈分析

第14章：波特五力分析

第15章：價格分析

第16章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Antech Diagnostics, Inc.
    • bioMerieux
    • Bioneer Corporation
    • HealthGene Corp.
    • IDEXX
    • INDICAL BIOSCIENCE GmbH
    • Ingenetix GmbH
    • Neogen Corporation
    • Novacyt Group
    • Thermo Fisher Scientific Inc.
    • Veterinary Molecular Diagnostics Inc.
    • Zoetis Services LLC
Product Code: SR112026A5121

The global veterinary molecular diagnostics market size reached USD 801.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,532.3 Million by 2034, exhibiting a growth rate (CAGR) of 7.24% during 2026-2034. The growing adoption of pets among the masses, increasing advancements in molecular diagnostic technologies, and rising implementation of stringent regulatory guidelines and quality control standards to standardize molecular diagnostic tests in veterinary practice are some of the major factors propelling the market growth.

VETERINARY MOLECULAR DIAGNOSTICS MARKET ANALYSIS:

  • Major Market Drivers: Increasing pet ownership is one of the significant factors driving the growth of the market. Additionally, the rising demand for molecular diagnostics that can rapidly and accurately detect infectious agents in animals, helping to prevent disease transmission to humans and safeguard public health, is impelling the growth of the market.
  • Key Market Trends: The rising utilization of personalized medicine in veterinary care to tailor treatment plans and predict disease susceptibility is creating a positive outlook for the overall market.
  • Competitive Landscape: Some of the leading veterinary molecular diagnostics companies include Antech Diagnostics, Inc., bioMerieux, Bioneer Corporation, HealthGene Corp., IDEXX, INDICAL BIOSCIENCE GmbH, Ingenetix GmbH, Neogen Corporation, Novacyt Group, Thermo Fisher Scientific Inc., Veterinary Molecular Diagnostics Inc., and Zoetis Services LLC, among others.
  • Geographical Trends: According to the report, North America accounted for the largest market share. This can be attributed to the rising adoption of pets among the masses to enjoy their companionship. Besides this, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market.
  • Challenges and Opportunities: Challenges in veterinary molecular diagnostics include the need for cost-effective and user-friendly technologies, as well as the requirement for extensive validation to ensure accuracy across diverse animal species. Opportunities lie in the development of rapid, point-of-care assays for timely diagnosis and the potential for personalized treatment plans based on genetic information, advancing animal health care.

VETERINARY MOLECULAR DIAGNOSTICS MARKET TRENDS:

Growing Adoption of Pets Among the Masses

The growing adoption of pets among the masses is positively influencing the veterinary molecular diagnostics market. This surge in pet ownership is resulting in a higher demand for veterinary services, including diagnostics. For instance, according to the pet population data published in March 2021 by the Pet Food Manufacturers Association, over 59% of households in the United Kingdom had pets, with over 32.6 million pets in 2021. The trend of treating pets as family members is growing, which in turn is augmenting the veterinary molecular diagnostics market demand. Moreover, dogs and cats are the popular pets adopted by pet parents. For instance, the dog population was around 604.5 million in 2022, whereas the cat population was approx. 408.2 million globally. Besides this, the American Pet Products Association published in April 2022 that the total American pet industry expenditure reached US$ 123.6 Billion in 2021, up from US$ 103.6 Billion in 2020. The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for various disease conditions in animals and propel the veterinary molecular diagnostics market's recent price.

Rising Prevalence of Animal Diseases

The rising prevalence of animal diseases is bolstering the growth of the veterinary molecular diagnostics market. According to a study published by the University of Calgary in June 2021, conducted to investigate the infections of Echinococcus multilocularis in domestic dogs to infer their potential role in zoonotic transmission, stated that Echinococcus multilocularis, a parasitic helminth of the northern hemisphere (Alberta, Canada), normally cycles through definitive and intermediate hosts. But in urban areas, domestic dogs can also become hosts for this parasite, which could become a significant risk factor to humans due to their proximity. Besides this, it is estimated that one in five farm animals is lost due to diseases each year, while many more animals suffer the effects of illness. According to an article published by Emerging Pathogen Institutes in November 2021, bovine respiratory diseases account for 75% of feedlot illnesses, and economic losses to cattle producers exceed US$ 1 Billion every year. The estimated costs for pinkeye are US$ 150 Million yearly, and losses to dairy producers due to foot rot range from US$ 120 to US$ 350 per animal. Such increasing losses and genetic disorders among animals are expected to drive the demand for veterinary molecular diagnostics, thereby augmenting the veterinary molecular diagnostics market share.

Increasing Advancements in Molecular Diagnostic Technologies

The increasing advancements in molecular diagnostic technologies are bolstering the growth of the market. Cutting-edge molecular diagnostic technologies, such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray analysis, are continually evolving to provide veterinarians with unparalleled insights into the health of animals. Moreover, various key market players are launching improved diagnostics kits and instruments to facilitate quality diagnosis and treatments. For instance, in April 2022, Carolina Liquid Chemistries Corp of Greensboro signed a semi-exclusive agreement to distribute a portable analyzer for the US veterinary market. The company distributed the SeamatySMT-120 VP veterinary automated chemistry analyzer, a compact, fully automatic chemistry, electrolyte immunoassay, and coagulation analyzer for animal health diagnosis. Similarly, in September 2021, Micro Vet Diagnostics launched Micro-chem II, a completely new chemistry, electrolyte, immunoassay, and coagulation analyzer for animal health, producing accurate reference and laboratory-quality results. Such innovations are enhancing the efficiency of veterinary laboratories and enabling quicker turnaround times for test results, which is anticipated to propel veterinary molecular diagnostics market revenue in the coming years.

GLOBAL VETERINARY MOLECULAR DIAGNOSTICS INDUSTRY SEGMENTATION:

Breakup by Product:

  • Kits and Reagents
  • Instruments
  • Software and Services

Kits and reagents dominate the market

The veterinary molecular diagnostics market report has provided a detailed breakup and analysis of the market based on the product. This includes kits and reagents, instruments, and software and services. According to the report, kits and reagents represented the largest segment.

In veterinary molecular diagnostics, various kits and reagents are required to conduct tests and experiments to detect and analyze nucleic acids from animal samples. These molecular diagnostic tools are used for a wide range of purposes, including disease detection, genotyping, pathogen identification, and genetic research in animals. Kits and reagents for next-generation sequencing (NGS) are employed to characterize the genomes of pathogens, aiding in the study of their evolution, drug resistance, and virulence factors. They also enable the study of epigenetic modifications in animal DNA, providing insights into gene regulation and potential links between epigenetic changes and disease susceptibility.

Breakup by Technology:

  • Real Time PCR
  • Microarray
  • DNA Sequencing

Real time PCR holds the largest share in the market

Real-time PCR (Polymerase Chain Reaction) in Veterinary Molecular Diagnostics is a molecular biology technique used to amplify and quantify DNA in real-time during the PCR process. It is a sensitive and accurate method for measuring the amount of a target DNA or RNA molecule in a biological sample. Real-time PCR is widely employed to examine and quantify pathogens in animals, including viruses, bacteria, fungi, and parasites. It also allows for early and accurate diagnosis, enabling prompt treatment and disease management.

Breakup by Animal Type:

  • Companion Animal
  • Livestock Animal

Companion animal holds the biggest share in the market

As per the veterinary molecular diagnostics market statistics by IMARC, the increasing trend of pet humanization is contributing to the growth of this segment. Companion animals, like dogs, cats, and other pets, require veterinary molecular diagnostics to detect diseases and health conditions. Some companion animals are prone to genetic disorders or inherited diseases. The rising pet ownership and growing consciousness of pet parents regarding the health of their pets are bolstering the market for molecular diagnostics. For instance, there are over 31 million pet dogs and around 2.44 million pet cats in India. The pet cat population may reach 4.89 million by 2026. 11% of people in India own at least four pets. Molecular diagnostics can identify genetic mutations or markers associated with these conditions, allowing breeders to make informed decisions about breeding and helping veterinarians manage the health of affected animals. Molecular tests can rapidly identify the presence of infectious agents, including viruses, bacteria, and parasites. This is crucial for diagnosing and managing diseases like parvovirus, feline leukemia, and Lyme disease.

Breakup by Disease Type:

  • Vector-borne Diseases
  • Respiratory Pathogens
  • Diarrhea Pathogens
  • Others

Vector-borne diseases hold the maximum share in the market

Vector-borne diseases in animals are infections that are transmitted from one animal to another through the bites of arthropod vectors, similar to how these diseases are transmitted to humans. They can have significant economic impacts on agriculture and can reduce the productivity of livestock, decrease meat and milk production, and even lead to animal deaths. Molecular diagnostic methods, like PCR, swiftly and precisely identify the genetic material of pathogens causing vector-borne diseases in animals, crucial for efficient disease control. Such techniques aid in tracking disease advancement in infected animals, enabling veterinarians to gauge infection severity and adapt treatment strategies accordingly.

Breakup by End User:

  • Veterinary Hospitals
  • Clinical Laboratories
  • Research Institutes

The veterinary molecular diagnostics market overview indicates that veterinary molecular diagnostics plays a crucial role in veterinary hospitals by offering advanced tools and techniques for the monitoring and treatment of diseases in animals. They can be used in biosecurity protocols to quickly identify and isolate infected animals, preventing the spread of contagious diseases within veterinary hospitals and breeding facilities.

Veterinary molecular diagnostics plays a pivotal role in clinical laboratories dedicated to animal healthcare. These sophisticated techniques harness the power of molecular biology to provide rapid, precise, and comprehensive insights into the health of animals. Besides this, in research institutes focused on enhancing understanding of animal health, genetics, and disease mechanisms, veterinary molecular diagnostics is essential. Utilizing state-of-the-art molecular methods like Polymerase Chain Reaction (PCR), DNA sequencing, and genotyping, these institutes conduct diverse studies benefiting both animal and human welfare.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest veterinary molecular diagnostics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the rising adoption of pets among the masses to enjoy their companionship. For instance, according to pet ownership statistics by Forbes, pet ownership in the U.S. jumped significantly over the past three decades. As of 2024, 66% of U.S. households (86.9 million homes) own a pet. That is up from 56% in 1988. Moreover, the rise in the prevalence of animal diseases and injuries is also a major factor bolstering the market growth. According to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA), the annual expenditure on a routine visit for dogs accounts for US$ 242 and US$ 178 for cats in the country. Furthermore, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market. Apart from this, the escalating number of product launches in North America that focus on molecular diagnostics for animals drives the market growth. For instance, in January 2022, IDEXX Laboratories, Inc. expanded its reference laboratory menu of tests and services that will enable veterinarians to better meet the challenges of diagnosing and treating cancer. Such activities are expected to positively impact the veterinary molecular diagnostics market outlook in the coming years.

COMPETITIVE LANDSCAPE:

Key market players are developing innovative and more accurate diagnostic tests for animals by creating new assays, improving the sensitivity and specificity of existing tests, and expanding their test menu to cover a broader range of diseases. They are also expanding their product portfolios to include a wider range of diagnostic tests for different animal species, including companion animals (dogs and cats), livestock (cattle, pigs, and poultry), and exotic animals. Top companies are establishing partnerships or collaborations with distributors and veterinary clinics in different regions to reach a global customer base. They are also incorporating automation and advanced technologies into their diagnostic platforms to streamline testing processes, reduce turnaround times, and enhance the accuracy of results.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Antech Diagnostics, Inc.
  • bioMerieux
  • Bioneer Corporation
  • HealthGene Corp.
  • IDEXX
  • INDICAL BIOSCIENCE GmbH
  • Ingenetix GmbH
  • Neogen Corporation
  • Novacyt Group
  • Thermo Fisher Scientific Inc.
  • Veterinary Molecular Diagnostics Inc.
  • Zoetis Services LLC

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Kits and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Real Time PCR
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Microarray
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Animal Type

  • 8.1 Companion Animal
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Livestock Animal
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Disease Type

  • 9.1 Vector-borne Diseases
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Respiratory Pathogens
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diarrhea Pathogens
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Veterinary Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinical Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Antech Diagnostics, Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 bioMerieux
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Bioneer Corporation
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 HealthGene Corp.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 IDEXX
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 INDICAL BIOSCIENCE GmbH
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Ingenetix GmbH
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Neogen Corporation
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Novacyt Group
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Thermo Fisher Scientific Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Veterinary Molecular Diagnostics Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Zoetis Services LLC
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Veterinary Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Veterinary Molecular Diagnostics Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Veterinary Molecular Diagnostics Market: Breakup by Technology (in %), 2025
  • Figure 6: Global: Veterinary Molecular Diagnostics Market: Breakup by Animal Type (in %), 2025
  • Figure 7: Global: Veterinary Molecular Diagnostics Market: Breakup by Disease Type (in %), 2025
  • Figure 8: Global: Veterinary Molecular Diagnostics Market: Breakup by End User (in %), 2025
  • Figure 9: Global: Veterinary Molecular Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 10: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Veterinary Molecular Diagnostics (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Veterinary Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Veterinary Molecular Diagnostics (Software and Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Veterinary Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Veterinary Molecular Diagnostics (Microarray) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Veterinary Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Veterinary Molecular Diagnostics (Companion Animal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Veterinary Molecular Diagnostics (Companion Animal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Veterinary Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Veterinary Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: North America: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: North America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: United States: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: United States: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Canada: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Canada: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Asia-Pacific: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Asia-Pacific: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: China: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: China: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Japan: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Japan: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: India: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: India: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: South Korea: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: South Korea: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Australia: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Australia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Indonesia: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Indonesia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Europe: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Europe: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Germany: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Germany: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: France: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: France: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: United Kingdom: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: United Kingdom: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Italy: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Italy: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Spain: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Spain: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Russia: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Russia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Latin America: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Latin America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Brazil: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Brazil: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Mexico: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Mexico: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Middle East and Africa: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Middle East and Africa: Veterinary Molecular Diagnostics Market: Breakup by Country (in %), 2025
  • Figure 88: Middle East and Africa: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Global: Veterinary Molecular Diagnostics Industry: SWOT Analysis
  • Figure 90: Global: Veterinary Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 91: Global: Veterinary Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Veterinary Molecular Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Animal Type (in Million USD), 2026-2034
  • Table 5: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Disease Type (in Million USD), 2026-2034
  • Table 6: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 7: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Veterinary Molecular Diagnostics Market: Competitive Structure
  • Table 9: Global: Veterinary Molecular Diagnostics Market: Key Players